Related Experiment Video
Updated: May 15, 2026
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Substance abuse and pregnancy: "we have a problem"
1Department of Obstetrics and Gynecology, Maternal-Fetal Medicine, Sarasota Memorial Hospital, Sarasota, FL, USA. washington-hill@smh.com
Clinical Obstetrics and Gynecology
|January 15, 2013
Summary
This case study addresses the complex care of a pregnant patient at 31 weeks gestation experiencing preterm labor amidst polysubstance use and hepatitis C. It outlines immediate management strategies and explores options for maternal and neonatal care, focusing on harm reduction and patient support.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Neonatal Care
Background:
- A 31-week pregnant patient presents with preterm labor, a history of no prenatal care, and polysubstance use (cocaine, methadone, marijuana).
- The patient expresses a desire for substance use treatment to benefit her fetus and requests confidentiality regarding her drug use from the father.
- Co-existing conditions include positive hepatitis C status and potential fetal well-being concerns due to decreased fetal movement.
Discussion:
- Immediate management involves stabilizing preterm labor, addressing acute substance withdrawal, and comprehensive maternal assessment.
- Ethical considerations include patient autonomy, confidentiality, mandatory reporting laws, and the potential for child protective services involvement.
- Multidisciplinary care is essential, involving obstetrics, neonatology, addiction specialists, social work, and mental health professionals.
Key Insights:
- Polysubstance use in pregnancy complicates preterm labor management and necessitates a harm reduction approach.
- Balancing patient confidentiality with the need to ensure fetal and neonatal safety is a critical challenge.
- Early and ongoing substance use disorder treatment and support services are vital for improving maternal and infant outcomes.
Outlook:
- Developing integrated care models for pregnant individuals with substance use disorders is crucial.
- Further research on long-term outcomes for neonates exposed to polysubstance use in utero is warranted.
- Enhancing prenatal care access and reducing stigma associated with substance use can improve engagement and outcomes.
More Related Videos
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
15:27Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
Related Concept Videos
01:24Substance Use Disorders Affecting Sleep
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:17Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
01:30Stress and Mental Health
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:26Stress Prevention and Stress Management Techniques IV
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...